The larger cohort of MMR-deficient IDH-mutant astrocytoma in the present study likely allowed the detection of more subtle differences in the DNA methylation profile, which are otherwise obscured in comparison to non-IDH mutant cohorts. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).